Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 04, 2015 5:51 AM ET

Life Sciences Tools and Services

Company Overview of Special Diversified Opportunities Inc.

Executive Profile

Wayne P. Yetter

Director, Chairman of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Audit Committee, Special Diversified Opportunities Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 13 different industries.

See Board Relationships
69$36,050

Background

Mr. Wayne P. Yetter has been the Chief Executive Officer since October 2009, and serves as an Executive Chairman of ProActive for Patients Media, Inc. Mr. Yetter served as the Chief Executive Officer at Verispan L.L.C from September 2005 to August 2008. From November 22, 2004 to September 2005, he served as the President and Chief Executive Officer at Odyssey Pharmaceuticals Inc. Mr. Yetter served as an Advisor at Alterity Partners from 2003 to 2005. He served as the ...

Corporate Headquarters

1521 Concord Pike
Wilmington, Delaware 19803

United States

Phone: 302-824-7062
Fax: 302-504-4780

Board Members Memberships

Former Director
1999-N/A
Former Director
2000-N/A
Former Chairman of the Board and Chief Executive Officer
2001-Present
Non Executive Chairman
2003-N/A
Former Director, Chairman of Compensation Committee and Member of Audit Committee
2004-N/A
Former Member of Board of Directors, Chairman of Corporate Governance & Nominating Committee and Member of Compensation Committee
2005-Present
Director
2005-Present
Independent Director, Member of Compensation Committee and Member of Governance & Nominating Committee
2006-2012
Former Director, Chairman of Corporate Governance & Nominating Committee and Member of Audit Committee
2006-N/A
Former Director, Member of Audit Committee, Member of Compensation Committee and Member of Nominating Committee
2010-Present
Director, Chairman of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Audit Committee
2010-Present
Chairman and Member of Audit Committee

Education

MBA
Bryant University
BA
Wilkes University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Exercisable Options$71,304
Total Number of Options$71,304

Total Compensation

Total Annual Cash Compensation$30,550
Total Calculated Compensation$36,050
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jonathan W. Ayers Chairman, Chief Executive Officer and President
IDEXX Laboratories, Inc.
$800.0K
James L. Herbert Chairman and Chief Executive Officer
Neogen Corp.
$532.0K
Ronan O’Caoimh Co-Founder, Chairman, Chief Executive Officer and Chairman of Compensation Committee
Trinity Biotech plc
$949.0K
Douglas A. Michels Chief Executive Officer, President and Director
OraSure Technologies, Inc.
$580.1K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Special Diversified Opportunities Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.